Pål Dag Line

Pål Dag Line is a Professor in the Department of Transplantation at the University of Oslo. His research focuses on surgical oncology, particularly liver transplantation for colorectal liver metastases and primary sclerosing cholangitis. He leads clinical trials evaluating metabolic tumor volume and PET/CT imaging for predicting transplant outcomes. His work also addresses immunosuppressive therapy optimization and pancreatic transplant outcomes.

Key contributions include the SECA study on long-term survival after liver transplantation, guidelines for colorectal liver metastasis management, and studies on graft thrombosis mechanisms. He is affiliated with the Transplant Oncology research group and collaborates internationally on consensus guidelines for transplantation practices.